To explore the mechanism underlying the effect of docetaxel and quercetin combination treatment on prostate cancer, the apoptosis protein (Bax and Bcl-2) expression level and the level of activity via a classic signaling pathway (PI3K/Akt pathway) was evaluated by Western blotting (Figure 7a). This evidence concerns the gene AKT1 and prostate cancer.